165 related articles for article (PubMed ID: 38367748)
1. The multifaceted role of the CXC chemokines and receptors signaling axes in ALS pathophysiology.
La Cognata V; Morello G; Guarnaccia M; Cavallaro S
Prog Neurobiol; 2024 Apr; 235():102587. PubMed ID: 38367748
[TBL] [Abstract][Full Text] [Related]
2. CXCL13/CXCR5 signalling is pivotal to preserve motor neurons in amyotrophic lateral sclerosis.
Trolese MC; Mariani A; Terao M; de Paola M; Fabbrizio P; Sironi F; Kurosaki M; Bonanno S; Marcuzzo S; Bernasconi P; Trojsi F; Aronica E; Bendotti C; Nardo G
EBioMedicine; 2020 Dec; 62():103097. PubMed ID: 33161233
[TBL] [Abstract][Full Text] [Related]
3. Molecular characterization, structural and expression analysis of twelve CXC chemokines and eight CXC chemokine receptors in largemouth bass (Micropterus salmoides).
Qi Z; Xu Y; Dong B; Pi X; Zhang Q; Wang D; Wang Z
Dev Comp Immunol; 2023 Jun; 143():104673. PubMed ID: 36858298
[TBL] [Abstract][Full Text] [Related]
4. The Inflammatory Puzzle: Piecing together the Links between Neuroinflammation and Amyotrophic Lateral Sclerosis.
He D; Xu Y; Liu M; Cui L
Aging Dis; 2024 Feb; 15(1):96-114. PubMed ID: 37307819
[TBL] [Abstract][Full Text] [Related]
5. CXC chemokine mRNA expression as a potential diagnostic tool in prostate cancer.
Wedel SA; Raditchev IN; Jones J; Juengel E; Engl T; Jonas D; Blaheta RA
Mol Med Rep; 2008; 1(2):257-62. PubMed ID: 21479406
[TBL] [Abstract][Full Text] [Related]
6. Implication of HMGB1 signaling pathways in Amyotrophic lateral sclerosis (ALS): From molecular mechanisms to pre-clinical results.
Paudel YN; Angelopoulou E; Piperi C; Othman I; Shaikh MF
Pharmacol Res; 2020 Jun; 156():104792. PubMed ID: 32278047
[TBL] [Abstract][Full Text] [Related]
7. Purinergic implication in amyotrophic lateral sclerosis-from pathological mechanisms to therapeutic perspectives.
Cieślak M; Roszek K; Wujak M
Purinergic Signal; 2019 Mar; 15(1):1-15. PubMed ID: 30430356
[TBL] [Abstract][Full Text] [Related]
8. Motor neuron dysfunction in a mouse model of ALS: gender-dependent effect of P2X7 antagonism.
Cervetto C; Frattaroli D; Maura G; Marcoli M
Toxicology; 2013 Sep; 311(1-2):69-77. PubMed ID: 23583883
[TBL] [Abstract][Full Text] [Related]
9. CXC family of chemokines as prognostic or predictive biomarkers and possible drug targets in colorectal cancer.
Cabrero-de Las Heras S; Martínez-Balibrea E
World J Gastroenterol; 2018 Nov; 24(42):4738-4749. PubMed ID: 30479461
[TBL] [Abstract][Full Text] [Related]
10. Protective and Toxic Neuroinflammation in Amyotrophic Lateral Sclerosis.
Hooten KG; Beers DR; Zhao W; Appel SH
Neurotherapeutics; 2015 Apr; 12(2):364-75. PubMed ID: 25567201
[TBL] [Abstract][Full Text] [Related]
11. Suppression of adenosine 2a receptor (A2aR)-mediated adenosine signaling improves disease phenotypes in a mouse model of amyotrophic lateral sclerosis.
Ng SK; Higashimori H; Tolman M; Yang Y
Exp Neurol; 2015 May; 267():115-22. PubMed ID: 25779930
[TBL] [Abstract][Full Text] [Related]
12. Dysregulation of chemokine receptor expression and function in leukocytes from ALS patients.
Perner C; Perner F; Stubendorff B; Förster M; Witte OW; Heidel FH; Prell T; Grosskreutz J
J Neuroinflammation; 2018 Mar; 15(1):99. PubMed ID: 29592817
[TBL] [Abstract][Full Text] [Related]
13. Targeting Extracellular Cyclophilin A Reduces Neuroinflammation and Extends Survival in a Mouse Model of Amyotrophic Lateral Sclerosis.
Pasetto L; Pozzi S; Castelnovo M; Basso M; Estevez AG; Fumagalli S; De Simoni MG; Castellaneta V; Bigini P; Restelli E; Chiesa R; Trojsi F; Monsurrò MR; Callea L; Malešević M; Fischer G; Freschi M; Tortarolo M; Bendotti C; Bonetto V
J Neurosci; 2017 Feb; 37(6):1413-1427. PubMed ID: 28011744
[TBL] [Abstract][Full Text] [Related]
14. Association of Regulatory T-Cell Expansion With Progression of Amyotrophic Lateral Sclerosis: A Study of Humans and a Transgenic Mouse Model.
Sheean RK; McKay FC; Cretney E; Bye CR; Perera ND; Tomas D; Weston RA; Scheller KJ; Djouma E; Menon P; Schibeci SD; Marmash N; Yerbury JJ; Nutt SL; Booth DR; Stewart GJ; Kiernan MC; Vucic S; Turner BJ
JAMA Neurol; 2018 Jun; 75(6):681-689. PubMed ID: 29507931
[TBL] [Abstract][Full Text] [Related]
15. Dysregulation of IGF-1/GLP-1 signaling in the progression of ALS: potential target activators and influences on neurological dysfunctions.
Shandilya A; Mehan S
Neurol Sci; 2021 Aug; 42(8):3145-3166. PubMed ID: 34018075
[TBL] [Abstract][Full Text] [Related]
16. Purinergic P2X
Mckenzie ADJ; Garrett TR; Werry EL; Kassiou M
ACS Chem Neurosci; 2022 May; 13(10):1479-1490. PubMed ID: 35512313
[TBL] [Abstract][Full Text] [Related]
17. Neuroprotective effects of the Sigma-1 receptor (S1R) agonist PRE-084, in a mouse model of motor neuron disease not linked to SOD1 mutation.
Peviani M; Salvaneschi E; Bontempi L; Petese A; Manzo A; Rossi D; Salmona M; Collina S; Bigini P; Curti D
Neurobiol Dis; 2014 Feb; 62():218-32. PubMed ID: 24141020
[TBL] [Abstract][Full Text] [Related]
18. Linking neuroinflammation to motor neuron degeneration in ALS: The critical role of CXCL13/CXCR5.
Arnoux A; Dupuis L
EBioMedicine; 2021 Jan; 63():103149. PubMed ID: 33278800
[No Abstract] [Full Text] [Related]
19. Modulation of the IGF1R-MTOR pathway attenuates motor neuron toxicity of human ALS SOD1
Granatiero V; Sayles NM; Savino AM; Konrad C; Kharas MG; Kawamata H; Manfredi G
Autophagy; 2021 Dec; 17(12):4029-4042. PubMed ID: 33749521
[TBL] [Abstract][Full Text] [Related]
20. MyomiRs and their multifaceted regulatory roles in muscle homeostasis and amyotrophic lateral sclerosis.
Giagnorio E; Malacarne C; Mantegazza R; Bonanno S; Marcuzzo S
J Cell Sci; 2021 Jun; 134(12):. PubMed ID: 34137441
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
